NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

Don't have an account? Subscribe



IMO welcomes extension of HPV Vaccine to boys

By Mindo - 09th Aug 2018

<span id=”docs-internal-guid-81d10643-7fff-4436-8040-31ac6ed21b5c”> </span>

<p dir=”ltr”><span>HPV is a group of over 200 viruses which can infect skin and mucous membranes. Some strains of HPV cause cancer, including pre-cancer. These include cancer of the cervix in women, other ano-genital cancers in men and women and cancers of the head and neck in men and women. Cervical cancer is the most common cancer caused by HPV. </span>

<p dir=”ltr”><span>The vaccine is safe and effective. </span>The vaccine is recommended by the World Health Organization, the National Immunisation Advisory Committee and the International Federation of Obstetricians and Gynaecologists. A HIQA report has recommended the extension of the existing school-based HPV programme to include boys.

<p dir=”ltr”><span>Dr Ina Kelly, Chairperson of the IMO Community & Public Health Medicine Committee </span><span>says that the “extension of the programme to boys has the capacity to significantly reduce incidence of HPV related cancers, through adding stronger community protection from this cancer-causing infection.”</span>

<p dir=”ltr”><span>Since 2010 the HPV vaccination has been offered to all girls in first year of secondary school or equivalent and a catch up programme was offered to all sixth year girls or equivalent between 2011 and 2014. This programme is delivered by HSE vaccination teams, led by Community Medical Doctors</span>

<div><span><br /></span></div>

0 responses to “IMO welcomes extension of HPV Vaccine to boys”

  1. Enda Carroll says:
    Between 05:30 – 07:30, but the whole video is excellent.

    In the UK, there’s an organisation called “HPV Action”, which is an amalgamation of 48 ‘independent’ organisations, whose stated aim is to reduce the health burden of HPV.

    HPV Action receives funding from the “Oral Health Foundation”. The Oral Health Foundation receives unrestricted funds (‘for educational purposes’) from Merck, the manufacturer of Gardasil.

    So, basically, Merck is funding surrogates to overemphasize the health burden of HPV in the populace.

    HPV Action is also liaising with the Joint Committee of Vaccination and Immunization (JCVI) of the UK, which oversees the childhood vaccination regimen.

    I get the feeling that the medial fraternity will be soon be faced with another Thalidomide-like scandal.

    Maybe give this vaccine to the MSM community. But we should hold off giving it to all the kids in this country, until we see the effects in 5-10 years in other countries.

    I KNOW I’m not the only one who thinks this. To the consultants with leverage and influence in the system; grow some testicles. “First do no harm”.

    I suggest:
    1. Wait to see the effects of this vaccine in other nations.
    2. Educate people about safe sexual practices. Female Hypergamy only entered society in the 60s, and male homosexuality was only mainstreamed in the 80’s – 90’s. A return to traditional societal sexual norms would dramatically reduce HPV-related cancer incidence.

Leave a Reply






Latest Issue
The Medical Independent 11th June 2024

You need to be logged in to access this content. Please login or sign up using the links below.


Most Read